Augmentace antidepresiv atypickými antipsychotiky v léčbě farmakorezistentní deprese

Warning

This publication doesn't include Institute of Computer Science. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Title in English	Augmentation of antidepressants with atypical antipsychotics in the treatment of pharmacoresistant depression
Authors	ČEŠKOVÁ Eva
Year of publication	2011
Type	Article in Periodical
Magazine / Source	Česká a slovenská psychiatrie
MU Faculty or unit	Central European Institute of Technology
Citation
Field	Psychiatry, sexuology
Keywords	augmentation; antidepressants; atypical antipsychotics; risperidone; olanzapine; aripiprazol; quetiapine; quatiapine XR
Description	Augmentation of antidepressants with atypical antipsychotics presents an often used strategy in the treatment of pharmacoresistant depression. This strategy is common in both out-patient and in-patient departments. Controlled studies were performed with risperidone, olanzapine, aripiprazol and quetiapine. Quetiapine XR it the first atypical antipsychotic in the Czech Republic proved as adjunctive treatment in depressive episodes non responding adequately to monotherapy with antidepressants.
Related projects:	The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.